Cargando…

Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis

The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrell, Fiona J., Kilian, Lena Marie, Elkins, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448136/
https://www.ncbi.nlm.nih.gov/pubmed/30858169
http://dx.doi.org/10.1042/BCJ20180867
_version_ 1783408640347078656
author Sorrell, Fiona J.
Kilian, Lena Marie
Elkins, Jonathan M.
author_facet Sorrell, Fiona J.
Kilian, Lena Marie
Elkins, Jonathan M.
author_sort Sorrell, Fiona J.
collection PubMed
description The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain relieves this auto-inhibition allowing auto-phosphorylation on the KD activation loop. We have determined the crystal structure of the PAK3 catalytic domain and by small angle X-ray scattering, the solution-phase structures of full-length inactive PAK1 and PAK3. The structures reveal a compact but elongated molecular shape that demonstrates that, together with multiple independent biophysical measurements and in contrast with previous assumptions, group A PAKs are monomeric both before and after activation, consistent with an activation mechanism of cis-auto-inhibition and initial cis-auto-phosphorylation, followed by transient dimerisation to allow trans-auto-phosphorylation for full activation, yielding a monomeric active PAK protein.
format Online
Article
Text
id pubmed-6448136
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-64481362019-04-16 Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis Sorrell, Fiona J. Kilian, Lena Marie Elkins, Jonathan M. Biochem J Research Articles The group A p21-activated kinases (PAKs) exist in an auto-inhibited form until activated by GTPase binding and auto-phosphorylation. In the auto-inhibited form, a regulatory domain binds to the kinase domain (KD) blocking the binding of substrates, and CDC42 or Rac binding to the regulatory domain relieves this auto-inhibition allowing auto-phosphorylation on the KD activation loop. We have determined the crystal structure of the PAK3 catalytic domain and by small angle X-ray scattering, the solution-phase structures of full-length inactive PAK1 and PAK3. The structures reveal a compact but elongated molecular shape that demonstrates that, together with multiple independent biophysical measurements and in contrast with previous assumptions, group A PAKs are monomeric both before and after activation, consistent with an activation mechanism of cis-auto-inhibition and initial cis-auto-phosphorylation, followed by transient dimerisation to allow trans-auto-phosphorylation for full activation, yielding a monomeric active PAK protein. Portland Press Ltd. 2019-04-15 2019-04-04 /pmc/articles/PMC6448136/ /pubmed/30858169 http://dx.doi.org/10.1042/BCJ20180867 Text en © 2019 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Sorrell, Fiona J.
Kilian, Lena Marie
Elkins, Jonathan M.
Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title_full Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title_fullStr Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title_full_unstemmed Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title_short Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in cis
title_sort solution structures and biophysical analysis of full-length group a paks reveal they are monomeric and auto-inhibited in cis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448136/
https://www.ncbi.nlm.nih.gov/pubmed/30858169
http://dx.doi.org/10.1042/BCJ20180867
work_keys_str_mv AT sorrellfionaj solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis
AT kilianlenamarie solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis
AT elkinsjonathanm solutionstructuresandbiophysicalanalysisoffulllengthgroupapaksrevealtheyaremonomericandautoinhibitedincis